LLY

884.96

-0.04%↓

NVO

141.87

+0.6%↑

UNH

482.42

-0.43%↓

JNJ

148.65

+0.6%↑

MRK

130.24

+0.4%↑

LLY

884.96

-0.04%↓

NVO

141.87

+0.6%↑

UNH

482.42

-0.43%↓

JNJ

148.65

+0.6%↑

MRK

130.24

+0.4%↑

LLY

884.96

-0.04%↓

NVO

141.87

+0.6%↑

UNH

482.42

-0.43%↓

JNJ

148.65

+0.6%↑

MRK

130.24

+0.4%↑

LLY

884.96

-0.04%↓

NVO

141.87

+0.6%↑

UNH

482.42

-0.43%↓

JNJ

148.65

+0.6%↑

MRK

130.24

+0.4%↑

LLY

884.96

-0.04%↓

NVO

141.87

+0.6%↑

UNH

482.42

-0.43%↓

JNJ

148.65

+0.6%↑

MRK

130.24

+0.4%↑

Search

Bio-Techne Corp

Geschlossen

Branche Gesundheitswesen

73.68 -1.19

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

73.34

Max

73.95

Schlüsselkennzahlen

By Trading Economics

Einkommen

22M

49M

Verkäufe

303B

303B

KGV

Branchendurchschnitt

50.636

23.904

EPS

0.48

Dividendenrendite

0.392

Gewinnspanne

0.016

Angestellte

3,050

EBITDA

8.2M

92M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+10.02 upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

0.39%

7.76%

Nächstes Ergebnis

6. Aug. 2024

Nächste Dividendenausschüttung

30. Aug. 2024

Nächstes Ex-Dividendendatum

15. Aug. 2024

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-468M

12B

Vorheriger Eröffnungskurs

74.87

Vorheriger Schlusskurs

73.68

Nachrichtenstimmung

By Acuity

50%

50%

113 / 369 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Bearish Evidence

Bio-Techne Corp Chart

Ähnliche Nachrichten

21. Juni 2024, 17:53 UTC

Wichtige Markttreiber

Shares of Four U.S. Banks Slide as Regulator Finds Living Wills Weaknesses

21. Juni 2024, 15:12 UTC

Wichtige Markttreiber

Hertz Shares Get a Lift After Upsized Bond Offering

21. Juni 2024, 23:45 UTC

Akquisitionen, Fusionen, Übernahmen

Nvidia Is Surging. Why That's a Problem for a Tech ETF. -- Barrons.com

21. Juni 2024, 22:19 UTC

Top News

Jury Convicts Milken Protégé Terren Peizer of Insider Trading -- WSJ

21. Juni 2024, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

21. Juni 2024, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

21. Juni 2024, 20:37 UTC

Top News

S&P 500 Clinches Third Straight Weekly Gain -- WSJ

21. Juni 2024, 20:08 UTC

Top News

Apple Says Regulatory Concerns Might Prevent Rollout of AI Features in Europe -- Update

21. Juni 2024, 19:22 UTC

Market Talk

Oil Futures Post Weekly Gain on Demand Expectations -- Market Talk

21. Juni 2024, 19:04 UTC

Market Talk

Higher Output, Easing Heat Pressure U.S. Natural Gas -- Market Talk

21. Juni 2024, 18:53 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Home Depot to Benefit from Diversified Consumer Base After Latest Acquisition -- Market Talk

21. Juni 2024, 18:41 UTC

Market Talk

Gold Slides in Cautious Market -- Market Talk

21. Juni 2024, 18:41 UTC

Market Talk

Global Equities Roundup: Market Talk

21. Juni 2024, 18:34 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

21. Juni 2024, 18:34 UTC

Market Talk

Mexico's Peso Gets Lift From Picks for New Cabinet -- Market Talk

21. Juni 2024, 17:53 UTC

Ergebnisse

Delta Stock Is a Winner. Its CEO Explains Why It Can Fly Higher. -- Barrons.com

21. Juni 2024, 17:43 UTC

Market Talk

U.S. Oil Rig Count Falls to 485 -- Market Talk

21. Juni 2024, 17:32 UTC

Top News

Apple Says Regulatory Concerns May Prevent Rollout of AI Features in Europe -- WSJ

21. Juni 2024, 17:16 UTC

Akquisitionen, Fusionen, Übernahmen

Penn Could be Getting a Buyout Offer. Wall Street Doesn't Agree on What It Means for the Stock. -- Barrons.com

21. Juni 2024, 17:06 UTC

Top News

Regulators Cite Big Banks, Including Goldman Sachs and JPMorgan, Over Living Wills -- WSJ

21. Juni 2024, 16:29 UTC

Market Talk

Strong USD a Pressure Point for Grains -- Market Talk

21. Juni 2024, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

21. Juni 2024, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

21. Juni 2024, 15:46 UTC

Market Talk

Gold Futures Slump as Strong U.S. Business Activity Boosts Dollar -- Market Talk

21. Juni 2024, 15:40 UTC

Market Talk

Citi Sees Chance of Sustained Oil Price Rally -- Market Talk

21. Juni 2024, 15:30 UTC

Market Talk

Canadian Core Retail Sales Rebound in April Seen as Encouraging -- Market Talk

21. Juni 2024, 14:59 UTC

Market Talk

U.S. Natural Gas Storage Build Meets Expectations -- Market Talk

21. Juni 2024, 14:49 UTC

Top News

Home Prices Hit a Record High -- Update

21. Juni 2024, 14:46 UTC

Market Talk

Mexico's Inflation Likely Edged Up in First Half of June -- Market Talk

21. Juni 2024, 14:30 UTC

Ergebnisse

Bank Stress Tests, PCE Inflation Data, Nike Earnings: What to Watch Next Week -- WSJ

Peer-Vergleich

Kursveränderung

Bio-Techne Corp Prognose

Kursziel

By TipRanks

10.02% Vorteil

12-Monats-Prognose

Durchschnitt 82 USD  10.02%

Hoch 95 USD

Tief 65 USD

Basierend auf 9 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Bio-Techne Corp – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

9 ratings

6

Buy

3

Halten

0

Sell

Technischer Score

By Trading Central

73.43 / 75.88Unterstützung & Widerstand

Kurzfristig

Bearish Evidence

Mittelfristig

Strong Bullish Evidence

Langfristig

Weak Bearish Evidence

Stimmung

By Acuity

113 / 369 Ranking in Gesundheitswesen

Nachrichtenstimmung

Neutral

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Bio-Techne Corp

Bio-Techne Corporation is a developer, manufacturer, and seller of life science reagents, instruments and services for the research, diagnostics, and bioprocessing markets. The Company operates through two segments: Protein Sciences and Diagnostics and Genomics. The Protein Sciences segment is a developer and manufacturer of biological reagents used in all aspects of life science research, diagnostics and cell and gene therapy. This segment also includes proteomic analytical tools, both manual and automated, that offer researchers and pharmaceutical manufacturers efficient options for automated western blot and multiplexed ELISA workflow. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits.